ctDNA and MRD | 2023 Best of GI Cancer Conference

preview_player
Показать описание
In this session, Dr Sam Klempner from Massachusetts General Hospital discusses the use of circulating tumor DNA (ctDNA) testing to monitor for minimal residual disease (MRD) in GI cancer.
  1. Total Health | Oncology
Рекомендации по теме
ctDNA and MRD 0:58:52

ctDNA and MRD | 2023 Best of GI Cancer Conference

Role of ctDNA 0:01:23

Role of ctDNA in MRD

ctDNA and MRD: 0:46:53

ctDNA and MRD: Who, When, and Then What? | 2022 Evolution Conference

Understand ctDNA Testing 0:03:25

Understand ctDNA Testing

Circulating Tumor DNA: 0:01:41

Circulating Tumor DNA: Enhanced Cancer Detection | Stanford Cancer Institute

Circulating Tumor DNA 0:01:48

Circulating Tumor DNA (ctDNA) and Overtreatment in NSCLC - OncTalk Lung 2023

Circulating Tumor DNA 0:02:28

Circulating Tumor DNA (ctDNA) in Breast Cancer: 2023 COEDS Ft Lauderdale Conference

The emerging role 0:02:53

The emerging role of MRD in colorectal cancer decision making

A Positive ctDNA 0:01:51

A Positive ctDNA Test after Adjuvant Therapy: 2023 Best of GI

ctDNA MRD as 0:01:09

ctDNA MRD as a biomarker for solid tumors

Pashtoon Kasi, MD, 0:01:39

Pashtoon Kasi, MD, MS | Patient Case - Using ctDNA and MRD Testing

The utility of 0:03:16

The utility of ctDNA in colorectal cancer management

ctDNA as a 0:08:45

ctDNA as a novel biomarker for MRD in CRC

GALAXY: ctDNA as 0:01:02

GALAXY: ctDNA as a prognostic biomarker in resected colorectal cancer

ctDNA for Patients 0:02:01

ctDNA for Patients with Breast Cancer

Diagnostics: ctDNA and 0:22:55

Diagnostics: ctDNA and MRD | Mark Lewis, MD | 2022 Review and Renew Sedona

ctDNA as an 0:03:30

ctDNA as an MRD biomarker for NSCLC

Evolving applications of 0:03:43

Evolving applications of ctDNA in lung cancer: MRD, early detection, and molecular profiling

Challenges associated with 0:01:04

Challenges associated with implementing ctDNA for MRD monitoring in breast cancer

Illumina Oncology | 0:04:25

Illumina Oncology | ctDNA-guided treatment in colorectal cancer

Fundamentals of ctDNA 0:04:26

Fundamentals of ctDNA

The emerging role 0:01:17

The emerging role of ctDNA analysis and liquid biopsies in oncology

ctDNA testing for 0:01:02

ctDNA testing for MRD – Reliable, sensitive, and specific, but challenges remain: 2022 ESMO Florida...

The clinical use 0:03:05

The clinical use of circulating tumor DNA in T-cell lymphomas